Analystreport

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $11.00 price target on the stock.

Sonoma Pharmaceuticals, Inc.  (SNOA) 
Last sonoma pharmaceuticals, inc. earnings: 2/14 05:13 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.sonomapharma.com